Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in acute optic neuritis
NCT00261326Phase 3Unknown
- Sponsor
- Rigshospitalet Glostrup
- Start
- Sep 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of simvastatin in optic neuritis (ON) and multiple sclerosis (MS), sponsored by Rigshospitalet Glostrup. Primary endpoint: Contrast sensitivity at 3 months. Status: unknown.
02
Drugs
simvastatin
03
Conditions
optic neuritis (ON)multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00261326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261326.